Novocure™ is a private commercial-stage oncology company dedicated to the advancement of tumor treating fields TTF therapy for patients with solid tumors. TTF therapy is an innovative antimitotic treatment that attempts to slow or reverse tumor progression by inducing tumor cell death.
Our company pioneered the concept that the electric properties of cells can be used as an effective target for an anti-neoplastic therapy. Founded by Professor Yoram Palti in 2000, Novocure has grown to become a global organization with employees in six countries. We have been fortunate throughout our expansion to attract a world class team with a shared passion to provide cancer patients with a new treatment option.
Novocure’s US operations are based in Portsmouth, NH. The Global Commercialization Team is located in New York City and the company maintains a research facility in Haifa, Israel. – less